August 14, 2018 — Guerbet LLC USA announced a commercial partnership with Imalogix, a provider of artificial intelligence (AI) process and workflow solutions. The Imalogix Platform gives healthcare organizations the tools to understand and manage the process, quality and safety related to diagnostic imaging and interventional procedures, and meet evolving regulatory standards surrounding radiation dose management with ease.
The commercial partnership combines Guerbet's capabilities in diagnostic and interventional imaging with the cloud-based human and machine-intelligence capabilities of Imalogix to proactively identify areas that impact care delivery. The goal is to reduce variability and improve the quality, safety and efficiency of care around radiation dose management.
The Imalogix self-learning neural network enables organizations to understand and benchmark in real-time best practices from the mass learnings across a network of providers to drive continuous improvement. Deep learning recommendations highlight where and how changes can be made to enable organizations to proactively change behavior down to the scanner, protocol and operator level. Insights into procedure length, utilization and workflow help organizations understand how to become more efficient and optimize patient flow.
For more information: www.guerbet.com, www.imalogix.com
May 29, 2024 
